X0202 SCHEDULE 13G/A 0001104659-24-132130 0001232258 XXXXXXXX LIVE 2 Common Stock, par value $0.001 per share 03/31/2026 0001810182 ALX ONCOLOGY HOLDINGS INC 00166B105 323 Allerton Avenue South San Francisco CA 94080 Rule 13d-1(c) HBM Healthcare Investments (Cayman) Ltd. E9 8590692.00 0.00 8590692.00 0.00 8590692.00 N 6.5 CO Voting and investment power over the shares held by HBM Healthcare Investments (Cayman) Ltd. is exercised by the board of directors of HBM Healthcare Investments (Cayman) Ltd. (the "Board"). The Board consists of Jean-Marc LeSieur, Richard H. Coles, Sophia Harris, Dr. Andreas Wicki, Mark Kronenfeld, M.D., and Richard Paul Woodhouse, none of whom has individual voting or investment power with respect to the shares. ALX ONCOLOGY HOLDINGS INC 323 Allerton Avenue, South San Francisco, CA, 94080 HBM Healthcare Investments (Cayman) Ltd. (the "Reporting Person") Governors Square, 23 Lime Tree Bay Avenue, PO Box 30852, Grand Cayman, KY1-1204, Cayman Islands Cayman Islands, British West Indies Y As of March 31, 2026, the Reporting Person may be deemed the beneficial owner of 8,590,692 shares of Common Stock. As of March 31, 2026, the Reporting Person may be deemed the beneficial owner of approximately 6.5% of the shares of Common Stock outstanding. The percentage set forth herein is calculated based on 131,608,278 shares of Common Stock outstanding as of March 2, 2026, as reported in the Issuer's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 9, 2026. 8,590,692 0 8,590,692 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. HBM Healthcare Investments (Cayman) Ltd. /s/ Jean-Marc LeSieur 05/15/2026